<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="14151">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02922660</url>
  </required_header>
  <id_info>
    <org_study_id>ZOCMZK-2016</org_study_id>
    <nct_id>NCT02922660</nct_id>
  </id_info>
  <brief_title>Desflurane Versus Total Intravenous Anesthesia in Ophthalmic Ambulatory Surgery</brief_title>
  <official_title>Comparison Of Desflurane Balanced Anesthesia Versus Total Intravenous Anesthesia in Patients Undergoing Ophthalmic Ambulatory Surgery: A Single Center, Prospective, Randomized, Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xiaoliang Gan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a single-center, randomized, prospective research which aims to investigate the
      advantages and disadvantages between desflurane balanced anesthesia and TIVA in ophthalmic
      ambulatory surgery, so that to evaluate a better anesthesia method in ophthalmic surgery
      through a large sample clinical study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Desflurane balanced anesthesia and total intravenous anesthesia(TIVA) are commonly used in
      ambulatory surgery, however, there was no clear evidence to discriminate the advantages and
      disadvantages between desflurane anesthesia and TIVA when used in ophthalmic ambulatory
      surgery. This study is designed to evaluate a better anesthesia method in ophthalmic surgery
      through a clinical study. This is a singlecenter, randomized, prospective study. 200 adult
      patients undergoing ophthalmic ambulatory surgery are enrolled in this study, and the
      patients are randomly and equally divided into two groups: Group TIVA(TIVA with propofol)
      and Group Des(desflurane).Group TIVA is maintained with propofol 50~150μg/kg/min,and
      remifentanil 0.1~0.5μg/kg/min, while group Des is maintained with desflurane ranged from
      0.5~1.5 MAC. Both groups of patients' bispectral index(BIS) values are maintained at 40~60
      intraoperatively. The primary outcome is awake time, the secondary outcomes include the stay
      time in the postoperative care unit, discharge time, incidence of postoperative nausea and
      vomiting (PONV), incidence of postoperative agitation, quality of recovery in 1 day
      postoperatively, as well as anesthesia cost,etc.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Single Blind (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Awake time</measure>
    <time_frame>From the ending time of anesthesia until the recovery time of patient's consciousness, assessed up to half an hour postoperatively.</time_frame>
    <description>&quot;Anesthesia ends&quot; means stop infusing or inhaling any anaesthetic.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Discharge time</measure>
    <time_frame>From the ending time of anesthesia until the time of extubation, assessed up to half an hour postoperatively.</time_frame>
    <description>The standards of extubation are tidal volume(VT) 6～8 ml/kg，respiratory rate(RR) 10～12 times per minute，end-tidal carbon dioxide (ETCO2) 35～45 mmHg.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stay time in the postoperative care unit</measure>
    <time_frame>Measuring the stay time in postoperative care unit, assessed up to one hour postoperatively.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of recovery in 1 day postoperatively</measure>
    <time_frame>Start scaling when 1 day(24 hour) postoperatively.</time_frame>
    <description>It will use telephone follow-up for the patients enrolled.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidences in postoperative nausea and vomiting(PONV)</measure>
    <time_frame>Start scaling in 1 day(24 hour) postoperatively.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidences in postoperative agitation</measure>
    <time_frame>Start scaling in 1 day(24 hour) postoperatively.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anesthesia cost</measure>
    <time_frame>During the procedure of anesthesia.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative VAS pain score</measure>
    <time_frame>Start scaling in half an hour postoperatively when patient's consciousness returns.</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Ophthalmic</condition>
  <condition>Surgery</condition>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Group TIVA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>method of anesthesia is total intravenous anesthesia(TIVA) and maintenance with propofol Cp 2—4 μg/ml and remifentanil 2—4 ng/ml in target controlled infusion(TCI) during the procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group Des</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>method of anesthesia is inhalation anesthesia and maintenance with desflurane ranged from 0.5~1.5 MAC during the procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>desflurane</intervention_name>
    <description>method of anesthesia maintenance with desflurane ranged from 0.5~1.5 MAC during the procedure</description>
    <arm_group_label>Group Des</arm_group_label>
    <other_name>Ethane,2--1,1,1,2-tetrafluoro</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>total intravenous anesthesia</intervention_name>
    <description>method of anesthesia in group TIVA is total intravenous anesthesia(TIVA) during the procedure</description>
    <arm_group_label>Group TIVA</arm_group_label>
    <other_name>TIVA</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>inhalation anesthesia</intervention_name>
    <description>method of anesthesia in group DES is inhalation anesthesia with desflurane during the procedure</description>
    <arm_group_label>Group Des</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>using propofol as sedative during the procedure of anesthesia and maintaining with propofol Cp 2—4 μg/ml in TCI</description>
    <arm_group_label>Group TIVA</arm_group_label>
    <other_name>Disoprofol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remifentanil</intervention_name>
    <description>using remifentanil as analgesics during the procedure of anesthesia and maintaining with remifentanil 2—4 ng/ml in TCI</description>
    <arm_group_label>Group TIVA</arm_group_label>
    <other_name>Remifentanil Hydrochloride for Injection</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-60 years patients undergoing selective ophthalmic ambulatory surgery；

          -  ASA I and II

          -  duration of anesthesia at least 30min

          -  without apparent organ comorbidities

          -  sign the informed consent form

        Exclusion Criteria:

          -  equal or greater than ASA III

          -  has a history of dementia，psychiatric disorders or central nervous system diseases

          -  taking sedatives, antidepressant or glucocorticoid

          -  without family members

          -  has cardiac, respiratory，liver，kidney comorbidities

          -  uncontrolled hypertension（&gt;180/100mmHg）

          -  laryngeal mask fail to insert, and change to tracheal intubation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yizhi Liu</last_name>
    <role>Study Chair</role>
    <affiliation>Zhongshan ophthalmic center, Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xiaoliang Gan</last_name>
    <phone>+86 13632391455</phone>
    <email>ganxiaoliang@yeah.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yanling Zhu</last_name>
    <phone>+86 18898600243</phone>
    <email>gzyan03@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zhongshan ophthalmic center, Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaoliang Gan, PhD</last_name>
      <phone>+86 13632391455</phone>
      <email>Ganxl_sysu@126.com</email>
    </contact>
    <contact_backup>
      <last_name>Yanling Zhu, MD</last_name>
      <phone>+86 18898600243</phone>
      <email>gzyan03@163.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Aylin P, Williams S, Jarman B, Bottle A. Trends in day surgery rates. BMJ. 2005 Oct 8;331(7520):803.</citation>
    <PMID>16210281</PMID>
  </reference>
  <reference>
    <citation>Neel ST. Effect of Conversion to Immediate Sequential Cataract Surgery on Ambulatory Surgery Centers in the United States in the Cost-Analysis Model. JAMA Ophthalmol. 2015 Jul;133(7):856-7. doi: 10.1001/jamaophthalmol.2015.0941.</citation>
    <PMID>25906175</PMID>
  </reference>
  <reference>
    <citation>Chen CH, Yang YL, Chen WM, Shyr MH. Comparison of the anesthesia profiles between sevoflurane-nitrous oxide and propofol-nitrous oxide conveyed by laryngeal mask airway in patients undergoing ambulatory gynecological surgery. Acta Anaesthesiol Taiwan. 2006 Jun;44(2):101-7.</citation>
    <PMID>16845915</PMID>
  </reference>
  <reference>
    <citation>Kumar G, Stendall C, Mistry R, Gurusamy K, Walker D. A comparison of total intravenous anaesthesia using propofol with sevoflurane or desflurane in ambulatory surgery: systematic review and meta-analysis. Anaesthesia. 2014 Oct;69(10):1138-50. doi: 10.1111/anae.12713. Epub 2014 May 22. Review.</citation>
    <PMID>24847783</PMID>
  </reference>
  <reference>
    <citation>Coskun D, Celebi H, Karaca G, Karabiyik L. Remifentanil versus fentanyl compared in a target-controlled infusion of propofol anesthesia: quality of anesthesia and recovery profile. J Anesth. 2010 Jun;24(3):373-9. doi: 10.1007/s00540-010-0898-1. Epub 2010 Mar 13.</citation>
    <PMID>20229001</PMID>
  </reference>
  <reference>
    <citation>Majholm B, Bartholdy J, Clausen HV, Virkus RA, Engbæk J, Møller AM. Comparison between local anaesthesia with remifentanil and total intravenous anaesthesia for operative hysteroscopic procedures in day surgery. Br J Anaesth. 2012 Feb;108(2):245-53. doi: 10.1093/bja/aer337. Epub 2011 Nov 23.</citation>
    <PMID>22113931</PMID>
  </reference>
  <reference>
    <citation>Eikaas H, Raeder J. Total intravenous anaesthesia techniques for ambulatory surgery. Curr Opin Anaesthesiol. 2009 Dec;22(6):725-9. doi: 10.1097/ACO.0b013e3283310f6b. Review.</citation>
    <PMID>19680121</PMID>
  </reference>
  <reference>
    <citation>Yoo YC, Bai SJ, Lee KY, Shin S, Choi EK, Lee JW. Total intravenous anesthesia with propofol reduces postoperative nausea and vomiting in patients undergoing robot-assisted laparoscopic radical prostatectomy: a prospective randomized trial. Yonsei Med J. 2012 Nov 1;53(6):1197-202. doi: 10.3349/ymj.2012.53.6.1197.</citation>
    <PMID>23074122</PMID>
  </reference>
  <reference>
    <citation>Rinehardt EK, Sivarajan M. Costs and wastes in anesthesia care. Curr Opin Anaesthesiol. 2012 Apr;25(2):221-5. doi: 10.1097/ACO.0b013e32834f00ec. Review.</citation>
    <PMID>22157199</PMID>
  </reference>
  <verification_date>October 2016</verification_date>
  <lastchanged_date>October 31, 2016</lastchanged_date>
  <firstreceived_date>September 28, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Xiaoliang Gan</investigator_full_name>
    <investigator_title>associate chief physician</investigator_title>
  </responsible_party>
  <keyword>Ambulatory surgery</keyword>
  <keyword>Ophthalmic</keyword>
  <keyword>Inhalation anesthesia</keyword>
  <keyword>Desflurane</keyword>
  <keyword>Total intravenous anesthesia</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Desflurane</mesh_term>
    <mesh_term>Isoflurane</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
